BRAF(V600E) induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation

Leukemia Research
Yo-Ting TsaiDavid M Lucas

Abstract

A subset of patients with chronic lymphocytic leukemia (CLL) and nearly all patients with classic hairy cell leukemia (HCL) harbor somatic BRAF activating mutations. However, the pathological role of activated BRAF in B-cell leukemia development and progression remains unclear. In addition, although HCL patients respond well to the BRAF(V600E) inhibitor vemurafenib, relapses are being observed, suggesting the development of drug resistance in patients with this mutation. To investigate the biological role of BRAF(V600E) in B-cell leukemia, we generated a CLL-like B-cell line, OSUCLL, with doxycycline-inducible BRAF(V600E) expression. Microarray and real-time PCR analysis showed that ABCB1 mRNA is upregulated in these cells, and P-glycoprotein (P-gp) expression as well as function were confirmed by immunoblot and rhodamine exclusion assays. Additionally, pharmacological inhibition of BRAF(V600E) and MEK alleviated the BRAF(V600E)-induced ABCB1/P-gp expression. ABCB1 reporter assays and gel shift assays demonstrated that AP-1 activity is crucial in this mechanism. This study, uncovers a pathological role for BRAF(V600E) in B-cell leukemia, and provides further evidence that combination strategies with inhibitors of BRAF(V600E) an...Continue Reading

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 11, 2007·Molecular Cancer Therapeutics·Kazuhiro KatayamaYoshikazu Sugimoto
Mar 14, 2008·Trends in Endocrinology and Metabolism : TEM·Efisio PuxedduDiego Russo
Sep 16, 2008·Molecular Cancer Therapeutics·Keiran S M SmalleyKatherine L Nathanson
Mar 14, 2009·Nature Genetics·David DankortMarcus Bosenberg
Mar 17, 2010·Journal of Cancer Research and Clinical Oncology·Chen ChenWen Lin Xu
Jun 4, 2010·Blood·Gayane Badalian-VeryBarrett J Rollins
Jul 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Eric W JosephNeal Rosen
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Mar 11, 2011·Molecular Cancer Therapeutics·Emma R Cantwell-DorrisOrla M Sheils
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 15, 2011·The New England Journal of Medicine·Enrico TiacciBrunangelo Falini
Dec 17, 2011·Pigment Cell & Melanoma Research·W DengM A Davies
Jan 11, 2012·Leukemia Research·Stephen E LangabeerElisabeth Vandenberghe
Mar 29, 2012·The Journal of Pharmacology and Experimental Therapeutics·Rajendar K MittapalliWilliam F Elmquist
May 25, 2012·The New England Journal of Medicine·Sascha DietrichThorsten Zenz
Oct 24, 2012·Leukemia & Lymphoma·Billy Michael Chelliah JebarajThorsten Zenz
Dec 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Muling MaoScott Kopetz
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sascha DietrichThorsten Zenz
Oct 25, 2013·Molecular Cancer Research : MCR·Tamihiro KamataAndrew D Leavitt
May 30, 2014·Science Translational Medicine·Stephen S ChungOmar Abdel-Wahab
Jun 13, 2014·Cancer Discovery·Frederik DammOlivier A Bernard
Oct 21, 2014·The Journal of Clinical Investigation·Niuscha YaktapourRobert Zeiser
Mar 5, 2016·Blood·Sascha DietrichThorsten Zenz

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
T Machii
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Javier MunozRazelle Kurzrock
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
T Kitani
Ryōikibetsu shōkōgun shirīzu
S Ito, S Kuriya
Indian Journal of Pathology & Microbiology
T SinghS Prakash
© 2021 Meta ULC. All rights reserved